Blue Lotus S1 by Massmedicalstrains
Indica × Sativa
Blue Lotus S1, developed by MassMedicalStrains, is a hybrid strain recognized for its complex genetic makeup, blending indica and sativa traits through experimental breeding. This strain has gained attention for its visually striking appearance and a nuanced aromatic and flavor profile, making it a notable option for both medicinal and recreational users.
Appearance
Blue Lotus S1 plants are characterized by a vibrant visual appeal, featuring deep green foliage often accented with purple and blue hues. The buds are notably dense and covered in a thick layer of trichomes, giving them a frosted appearance that signifies high resin production. Growers report sturdy plant structures with calyxes and pistils that can display blue and violet coloration, indicative of anthocyanin content.
Aroma & Flavor
The aroma of Blue Lotus S1 offers a complex bouquet, combining earthy and herbal notes with subtle floral sweetness and a hint of spice. Users frequently describe the scent as invigorating, with comparisons drawn to lavender and pine. The flavor profile mirrors the aroma, beginning with a refreshing citrus note, followed by earthy undertones and a natural sweetness. Hints of lemon zest and a mildly spicy finish are also noted, creating a layered sensory experience.
Effects
Blue Lotus S1 is reported to deliver a balanced set of effects, combining a sense of calm with cerebral stimulation. Users often experience uplifted moods and enhanced focus, making it suitable for various activities. The strain is noted for its potential to promote relaxation without significant sedation, contributing to its versatility for both daytime and evening use.
Terpenes & Cannabinoids
This strain typically exhibits THC levels ranging from 18% to 22%, with CBD content below 1%. Laboratory analyses have identified key terpenes such as Myrcene, Limonene, Caryophyllene, Linalool, and Pinene, which contribute to its distinct aroma, flavor, and effects. The cannabinoid profile, including the presence of minor cannabinoids like CBG, is thought to enhance its therapeutic properties, potentially aiding in pain management and mood stabilization.
Growing
Historical cultivation data suggests that Blue Lotus S1 demonstrates robust growth and resilience, with reported yield increases of up to 20% compared to similar strains. It also exhibits improved pest resistance. The strain is known for maintaining a consistent phenotype, which aids breeders in reliably reproducing its desirable characteristics and cannabinoid ratios.
Origins & Lineage
Blue Lotus S1 was developed by MassMedicalStrains through a careful yet experimental breeding process. Its genetic lineage is an intricate blend of indica and sativa genetics, engineered to emphasize specific phenotypic characteristics and cannabinoid expression. This balanced heritage is the result of selective breeding and hybridization, drawing inspiration from classical landraces fused with modern genetic innovations.